Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?

To: Miljenko Zuanic who wrote (9438)	11/7/2003 9:00:51 AM
From: Biomaven	Respond to of 52153

Randomization and groups baseline balance was compromised. The article contains details of the randomization process. The randomization sequence was made before the study, and the patients were enrolled sequentially after they were qualified. Seems an impeccable process to me - but given the size of the study and the lack of stratification it's not surprising that the groups were somewhat unbalanced. But the unbalanced groups matter a lot less than in most studies because this was not a cross-group study - here each patient was their own comparator. Peter